Aptevo Therapeutics Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $7.0M | $-112.4M | $-59.3M |
| Depreciation & Amortization | $3.1M | $3.4M | $2.9M |
| Depreciation | $1.5M | $1.1M | — |
| Amortization | $800.0K | $800.0K | $3.4M |
| Stock-Based Compensation | $4.9M | $3.8M | $1.1M |
| Net Cash from Operating Activities | $-41.6M | $-36.9M | $-48.8M |
| Investing Activities | |||
| Capital Expenditures | $1.4M | $2.5M | $1.5M |
| Business Acquisitions | — | — | — |
| Net Cash from Investing Activities | $29.5M | — | — |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $19.5M | — | — |
| Net Change in Cash | $-2.6M | $5.0M | $1.0M |
| Free Cash Flow | $-43.0M | $-39.4M | $-50.3M |